(Q51672008)
Statements
1 reference
Final overall survival results from a phase III, randomized, placebo-controlled, parallel-group study of gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804) (English)
1 reference
Hongyun Zhao
1 reference
Yun Fan
1 reference
Shenglin Ma
1 reference
Xiangqun Song
1 reference
Baohui Han
1 reference
Ying Cheng
1 reference
Cheng Huang
1 reference
Shujun Yang
1 reference
Xiaoqing Liu
1 reference
Yunpeng Liu
1 reference
Shun Lu
1 reference
Jie Wang
1 reference
Shucai Zhang
1 reference
Caicun Zhou
1 reference
Mengzhao Wang
1 reference
Li Zhang
1 reference
INFORM investigators
1 reference
1 April 2015
1 reference
10
1 reference
4
1 reference
655-664
1 reference
Identifiers
1 reference